Probiotics-2012 will bring together an international mix of biotech, food processing companies and leading universities to share experience, foster collaboration and evaluate emerging technologies in the field of probiotics. This conference will address basic research, clinical trials, regulatory efforts and development of industrial technologies. Leading scientists will present and discuss current advances in the research of probiotics. The scientific program will focus on current advances in the research, production and use of probiotics with particular focus on their role in maintaining health and preventing disease.
Dr. S.K. Dash to present criteria for selection of probiotics
The functional qualities of probiotics relate to the specific strain of micro-organism used, combined with critical techniques for commercial production and handling of the probiotic organisms. Dr. S.K. Dash, adjunct professor at South Dakota State University, has been a leader in the probiotic field since 1979. He has made many contributions that have furthered the field including; definition of the properties of bacterial strains that make them a good probiotic and the specific requirementsof manufacturing and handling probiotic strains for commercial viability. His presentation on Selection Criteria for Probiotics will address strain identity using genetic techniques and in vitro testing to establish probiotic qualities like acid and bile resistance, resistance to digestive enzymes, adherence to human epithelial cells, potential anti-microbial activity, affect on immune cytokines and sensitivity to common antibiotics. Recent human and animal research on probiotics will be reported. Dr. Dash will also describe stabilization techniques to ensure viability of probiotics throughout the supply chain along with Good Manufacturing Practices and considerations for condition-specific probiotic blends. The regulatory environment for probiotics continues to be an important consideration for selection and Dr. Dash will address regulations in the U.S., European Union and Canada.
About UAS Laboratories, Inc.
UAS Laboratories Inc. (Eden Prairie, Minn., USA), established in 1979, is one of the world’s leading biotechnology companies specializing in probiotic discovery, development, research, manufacture and marketing. The company manufactures products containing the trademarked, patented, Lactobacillus acidophilus DDS®-1, a probiotic with over 200 studies. DDS Probiotics are sold to natural products retailers, health professionals, private label customers and as probiotic raw materials and customer specific blends to manufacturers in the U.S., and over 48 other countries. UAS Labs was founded by Dr. S.K. Dash, the probiotic pioneer, in 1979. Dr. Dash has previously served as a member of the Board of Directors, Vice President and as a member of the Scientific Advisory Board at the International Probiotic Association and is an Adjunct Professor of Nutrition and Food Science at South Dakota State University. Dr. Dash’s research and innovations in probiotics have earned 2010 Probiotic Award from Frost and Sullivan to UAS Labs and recognition from the Minnesota State Senate.
For more information about UAS Laboratories Inc., please visit uaslabs.com.